Mitchel Tate

1.4k citations

29 papers · 1.1k indexed · h-index 17

Impact in

Endocrinology, Diabetes and Metabolism top 5%
- Diabetes Treatment and Management
Cardiology and Cardiovascular Medicine top 5%
- Cardiovascular Function and Risk Factors
- Cardiac Fibrosis and Remodeling

Papers in

Cardiology and Cardiovascular Medicine 15
- Cardiovascular Function and Risk Factors 10
- Cardiac Fibrosis and Remodeling 4
- Cardiomyopathy and Myosin Studies 4
Endocrinology, Diabetes and Metabolism 9
- Diabetes Treatment and Management 9

Co-authors: Rebecca H. Ritchie Arpeeta Sharma Judy B. de Haan David Grieve Emma Robinson Brian D. Green James E. Vince Geetha Mathew
Journals: European Heart Journal (3 papers)Frontiers in Physiology (3 papers)Clinical Science (2 papers)Basic Research in Cardiology (2 papers)Frontiers in Pharmacology (2 papers)
Partner nations: Australia United Kingdom United States

In The Last Decade

Mitchel Tate

28 papers receiving 1.1k citations

Peers

Countries citing papers authored by Mitchel Tate

Since Specialization

Citations

This map shows the geographic impact of Mitchel Tate's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchel Tate with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchel Tate more than expected).

Fields of papers citing papers by Mitchel Tate

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitchel Tate. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchel Tate. The network helps show where Mitchel Tate may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mitchel Tate, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mitchel Tate Line = papers co-authored together Mitchel Tate links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	MitoQ Protects Against Oxidative Stress-Induced Mitochondrial Dysregulation in Human Cardiomyocytes PubMed ·潘恩山, Jarmon G. Lees, Mitchel Tate, 潘庸鲁, J. A. MADDY, Minh Deo, Tammie Bishop, Thomas Krieg, Michael P. Murphy, Shiang Y. Lim, Miles J. De Blasio, Rebecca H. Ritchie	2025	2
2	Current landscape of preclinical models of diabetic cardiomyopathy Trends in Pharmacological Sciences ·Darnel Prakoso, Miles J. De Blasio, Mitchel Tate, Rebecca H. Ritchie	2022	19
3	Fine-tuning the cardiac O-GlcNAcylation regulatory enzymes governs the functional and structural phenotype of the diabetic heart Cardiovascular Research ·Darnel Prakoso, Shiang Y. Lim, Jeffrey R. Erickson, Rachel S. Wallace, Jarmon G. Lees, Mitchel Tate, Helen Kiriazis, D. Donner, Darren C. Henstridge, Jonathan R. Davey, Hongwei Qian, Minh Deo, Laura J. Parry, Amy J. Davidoff, Paul Gregorevic, John C. Chatham, Miles J. De Blasio, Rebecca H. Ritchie	2021	66
4	Characterisation of the Myocardial Mitochondria Structural and Functional Phenotype in a Murine Model of Diabetic Cardiomyopathy Frontiers in Physiology ·潘恩山, Mitchel Tate, Darnel Prakoso, Minh Deo, Dieter Lorenz, Sheng Yongwei, D. Donner, Simon Crawford, Helen Kiriazis, Cesare Granata, Melinda T. Coughlan, Miles J. De Blasio, Rebecca H. Ritchie	2021	16
5	Bone Morphogenetic Protein 7 Gene Delivery Improves Cardiac Structure and Function in a Murine Model of Diabetic Cardiomyopathy Frontiers in Pharmacology ·Mitchel Tate, Biyu He, Darnel Prakoso, Dieter Lorenz, Minh Deo, Liwei Lu, Hongwei Qian, D. Donner, Helen Kiriazis, Miles J. De Blasio, Paul Gregorevic, Rebecca H. Ritchie	2021	12
6	Characterising an Alternative Murine Model of Diabetic Cardiomyopathy Frontiers in Physiology ·Mitchel Tate, Darnel Prakoso, Dieter Lorenz, Cheng Peng, Minh Deo, Cheng Xue Qin, Wolfgang Potratz, Sheng Yongwei, Charles D. Cohen, Н. А. Огиенко, Arpeeta Sharma, Helen Kiriazis, D. Donner, Judy B. de Haan, Anna M.D. Watson, Miles J. De Blasio, Rebecca H. Ritchie	2019	25
7	Cardioprotective Actions of the Annexin-A1 N-Terminal Peptide, Ac2-26, Against Myocardial Infarction Frontiers in Pharmacology ·Cheng Xue Qin, Sarah Rosli, Minh Deo, Nga Cao, Wolfgang Potratz, Mitchel Tate, Amy E. Alexander, D. Donner, Duncan Horlock, J Tomcalová, Helen Kiriazis, Man K.S. Lee, Jane E. Bourke, Yuan Yang, Andrew Murphy, Xiao‐Jun Du, Yuhsuke Imai, Rebecca H. Ritchie	2019	31
8	The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart Cardiovascular Drugs and Therapy ·Mitchel Tate, Gavin C. Higgins, Miles J. De Blasio, Runa Lindblom, Darnel Prakoso, Minh Deo, Helen Kiriazis, Min Park, Athene Reiss, Stuart T. Caldwell, Richard C. Hartley, Thomas Krieg, Michael P. Murphy, Melinda T. Coughlan, Rebecca H. Ritchie	2019	15
9	Oxidative Stress and NLRP3-Inflammasome Activity as Significant Drivers of Diabetic Cardiovascular Complications: Therapeutic Implications Frontiers in Physiology ·Arpeeta Sharma, Mitchel Tate, Geetha Mathew, James E. Vince, Rebecca H. Ritchie, Judy B. de Haan	2018	170
10	Recent novel approaches to limit oxidative stress and inflammation in diabetic complications Clinical & Translational Immunology ·R. J. Pickering, Carlos J. Rosado, Arpeeta Sharma, James M Migwi, Mitchel Tate, Judy B. de Haan	2018	139
11	5213Manipulation of cardiac O-GlcNAc modification alters cardiac function and remodelling in the setting of diabetic cardiomyopathy European Heart Journal ·Darnel Prakoso, Helen Kiriazis, Mitchel Tate, Hongwei Qian, Ashwini Gade, Laura J. Parry, Paul Gregorevic, Xiao‐Jun Du, John C. Chatham, Miles J. De Blasio, Rebecca H. Ritchie	2018	5
12	The nuclear factor (erythroid-derived 2)-like 2 (Nrf2) activator dh404 protects against diabetes-induced endothelial dysfunction Cardiovascular Diabetology ·Arpeeta Sharma, N. Pernalete, Nada Stefanovic, Mitchel Tate, Rebecca H. Ritchie, Keith W. Ward, Judy B. de Haan	2017	78
13	P4461Cardiac-selective bone morphogenetic protein 7 (BMP7) gene therapy to target cardiac fibrosis in a mouse model of diabetic cardiomyopathy European Heart Journal ·Mitchel Tate, Liwei Lu, Miles J. De Blasio, Darnel Prakoso, Hongwei Qian, Helen Kiriazis, Zhenzhen Xun, Paul Gregorevic, Rebecca H. Ritchie	2017	0
14	Endogenous Annexin-A1 Regulates Haematopoietic Stem Cell Mobilisation and Inflammatory Response Post Myocardial Infarction in Mice In Vivo Scientific Reports ·Cheng Xue Qin, Malte Heuermann, Annas Al‐Sharea, Mitchel Tate, Miles J. De Blasio, Minh Deo, Sarah Rosli, Darnel Prakoso, Colleen J. Thomas, Helen Kiriazis, Takuo Morimoto, Yuan Yang, Eric F. Morand, Mauro Perretti, Andrew Murphy, Xiao‐Jun Du, Xiao‐Ming Gao, Rebecca H. Ritchie	2017	32
15	Gremlin1 plays a key role in kidney development and renal fibrosis American Journal of Physiology-Renal Physiology ·Z Sulowska, Imran Ali, Mitchel Tate, Deborah Lavin, 武田和行, 秀吉角, José R. Hombrebueno, Philip D. Dunne, Victoria Bingham, Roel Goldschmeding, Finian Martin, Derek P. Brazil	2017	61
16	Insulin replacement limits progression of diabetic cardiomyopathy in the low-dose streptozotocin-induced diabetic rat Diabetes and Vascular Disease Research ·Mitchel Tate, Minh Deo, Anh Cao, Sally G. Hood, Karina Huynh, Helen Kiriazis, Xiao‐Jun Du, Mohammad Shofiyulloh, Gemma A. Figtree, Gregory J. Dusting, David M. Kaye, Rebecca H. Ritchie	2017	38
17	Metabolically-inactive glucagon-like peptide-1(9–36)amide confers selective protective actions against post-myocardial infarction remodelling Cardiovascular Diabetology ·Emma Robinson, Mitchel Tate, Sam Lockhart, یاشار محرم زاد, 安元公正, Kevin Edgar, Danielle Calderwood, Brian D. Green, Barbara J. McDermott, David Grieve	2016	30
18	Exendin-4 attenuates adverse cardiac remodelling in streptozocin-induced diabetes via specific actions on infiltrating macrophages Basic Research in Cardiology ·Mitchel Tate, Emma Robinson, Brian D. Green, Barbara J. McDermott, David Grieve	2015	87
19	Exendin-4 protects against post-myocardial infarction remodelling via specific actions on inflammation and the extracellular matrix Basic Research in Cardiology ·Emma Robinson, Roslyn Cassidy, Mitchel Tate, Youyou Zhao, Sam Lockhart, Danielle Calderwood, Z Sulowska, Mary K. McGahon, Derek P. Brazil, Barbara J. McDermott, Brian D. Green, David Grieve	2015	61
20	Meeting American Diabetes Association Guidelines In Endocrinologist Practice Journal of the Peripheral Nervous System ·Chris D. Miller, Cen Pengrui, Mitchel Tate, M. V. Repyakh, 万文江, Viktor Mateev, Suzanne S P Gebhart	2000	2

About Mitchel Tate

Mitchel Tate is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Clinical Biochemistry, Nephrology and Immunology, having authored 29 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cardiovascular Function and Risk Factors (10 papers), Diabetes Treatment and Management (9 papers), Metabolism, Diabetes, and Cancer (5 papers), Cardiac Fibrosis and Remodeling (4 papers), Cardiomyopathy and Myosin Studies (4 papers), Pancreatic function and diabetes (4 papers), Pharmacology and Obesity Treatment (3 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (319 citations), Cardiology and Cardiovascular Medicine (350 citations), Clinical Biochemistry (79 citations), Molecular Biology (512 citations) and Nephrology (39 citations). Mitchel Tate has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include Rebecca H. Ritchie, Arpeeta Sharma, Judy B. de Haan, David Grieve, Emma Robinson, Brian D. Green, James E. Vince, Geetha Mathew, Barbara J. McDermott and Carlos J. Rosado. Their work appears in journals such as European Heart Journal, Frontiers in Physiology, Clinical Science, Basic Research in Cardiology and Frontiers in Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact